The ISSUP activities funded by the U.S. Department of State are temporarily suspended.
This website will remain live, but ISSUP is not currently monitoring or updating it. No new membership applications will be accepted or reviewed, no posts or comments will be possible, and members cannot login.
This information will be updated with any change in circumstances. Thank you for your understanding.

Edie

د اپیوایډ انحصار درملنې لپاره د میتادون په مقابل کې بوپرینورفین

Shared by Edie - 11 مې 2023
Translations
English
Português
Español
العربية
Pусский
Indonesian
Originally posted by Edie - 11 مې 2023

لنډیز

شالید

د اپیوایډ انحصار د پام وړ روغتیا او ټولنیز بارونو سره تړاو لری ، او د اپیوایډ اګینیسټ درملنه (OAT) د هغو خلکو لپاره د ډیری پایلو په ښه کولو کې خورا اغیزمنه ده چې دا درملنه ترلاسه کوی. میتادون او بوپرینورفین عام درمل دی چې د OAT په توګه چمتو شوی. موږ هدف لرو چې د لومړنی او ثانوی...

Published by / Citation
Degenhardt, L., Clark, B., Macpherson, G., Leppan, O., Nielsen, S., Zahra, E., ... & Farrell, M. (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry.
Format
Scientific article
Themes
Addiction
Treatment
Keywords
Opioid
Methadone
buprenorphine
Links
اصلی مقاله
0 comments
Contact Us

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy